BPC-157 is a synthetic 15-amino-acid peptide promoted online for tendon, muscle, gut, and injury recovery. Most of those claims run far ahead of controlled human evidence.
BPC-157 is investigational, not a Health Canada-authorized treatment. Laboratory and animal findings cannot establish human benefit, dosing, or long-term safety.
What is BPC-157?
BPC-157 is often described as a fragment related to a protective compound found in gastric juice. Research papers have explored possible effects on tissue repair, blood-vessel signalling, inflammation, and the nervous system. The large majority of that literature has been preclinical.
What does the human evidence show?
The human evidence base remains small. A 2025 publication reported a very small intravenous safety pilot; its authors called for further studies. A registered Phase 1 oral study from 2015 has no posted results on its ClinicalTrials.gov record. A newer Phase 2 hamstring-injury trial is registered with completion expected after this article’s review date. A trial plan is not a result.
This means the evidence cannot support broad claims that BPC-157 heals injuries, speeds recovery, treats gastrointestinal disease, or is safe for unsupervised use. It also cannot establish an appropriate formulation or route.
Canadian regulatory status
Health Canada’s April 9, 2026 public advisory explicitly lists BPC-157 as an example of an unauthorized injectable peptide drug. The agency advises consumers not to buy or use these products and says a “research use only” label does not make them safe or exempt.
No BPC-157 drug product was identified as authorized for sale in Health Canada’s Drug Product Database on the date checked. Because the database changes, readers should verify again using the official source.
What are the safety unknowns?
Small or absent human studies leave major gaps around adverse effects, interactions, immune reactions, effects on abnormal tissue or blood-vessel growth, pregnancy, long-term exposure, and differences between formulations. Unauthorized injectables also introduce product-level risks such as contamination, incorrect concentration, mislabelling, and non-sterile manufacture.
Sport status
BPC-157 is prohibited under the World Anti-Doping Agency’s non-approved substances category. Athletes are responsible for substances found in their samples and should use the current WADA list and Sport Integrity Canada resources rather than relying on a vendor.
Why the online story sounds stronger
Preclinical results, anecdotes, and mechanistic theories are easy to compress into the word “healing.” That compression removes the most important details: species, experimental model, formulation, outcome, study size, comparator, bias, and uncertainty. Commercial pages also have a financial reason to present preliminary research as settled.
This profile is not a recommendation. Do not buy or use unauthorized products. If you have used BPC-157 and have concerns, contact a licensed healthcare professional. In an emergency, call 911.
Source trail